Skip to content

Clinical trials

Terminated Phase 2/3 Multiple Sclerosis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 2/3 Status: Terminated Clear all

6 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20111
20131
20141
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated6

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Charite University, Berlin, Germany1
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's1
Neurologique Foundation, Inc.1
Nova Scotia Health Authority1
S. Andrea Hospital1
Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis6
Brain Injuries, Traumatic1
Cerebral Palsy1
Hemiplegia1
Muscle Spasticity1
Recurrence1
Sclerosis1
Spinal Cord Injuries1
Stroke1
Urinary Bladder, Neurogenic1

Trials

Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.